| Name | Title | Contact Details |
|---|
We envision a community in which people with enduring intellectual and physical disabilities are engaged fully and meaningfully in all aspects of community life. From accessible playgrounds to adaptive sports to special needs pre-vocational training, w...
Acculab Inc is a Marrero, LA-based company in the Business Services sector.
Sterne, Kessler, Goldstein and Fox PLLC is one of the leading companies in Business Services industry. Sterne, Kessler, Goldstein and Fox PLLC is based in Washington, DC. You can find more information on Sterne, Kessler, Goldstein and Fox PLLC at www.skgf.com
The Southeast Texas Healthcare Consortium is a Austin, TX-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.